Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.
about
Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@en
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@nl
type
label
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@en
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@nl
prefLabel
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@en
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@nl
P2093
P2860
P1433
P1476
Preclinical Study of a Combina ...... er Patient-Derived Xenografts.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11523-015-0415-4
P577
2016-01-28T00:00:00Z